Dr. Shelli F. Farhadian, MD, PhD

Dr. Farhadian practices at Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut.

Dr. Farhadian's NPI, 1104191311, was assigned on March 21, 2012. Dr. Farhadian graduated from JS Weill Medical College, Cornell University in 2012. Dr. Farhadian holds Connecticut license 60802.

Dr. Farhadian's primary practice is Yale New Haven Psychiatric Hospital (York St), at 20 York Street, New Haven, CT 06510. The practice phone is (203) 688-5900.

Dr. Farhadian's primary practice is Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut. Dr. Farhadian is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farhadian practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Farhadian's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Farhadian is board certified in infectious disease by the American Board of Internal Medicine. Dr. Farhadian is licensed in Connecticut.

CMS data shows 26 Medicare services from Dr. Farhadian across 1 procedure code in 2024, for 23 Medicare patients. Medicare paid $2,516 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Farhadian in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farhadian's median patient age at 64, with 35% women.

In 2024, Dr. Farhadian wrote 96 Medicare Part D claims for 14 patients. 63% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $62,986 in total drug cost. In 2017, CMS named 73 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Farhadian for performance year 2024, reported as part of a group. Dr. Farhadian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 69 papers to Dr. Farhadian, published from 2011 to 2025. 2021 was the busiest year, with 18. The most frequent topics are COVID-19, SARS-CoV-2 and HIV Infections. Dr. Farhadian has published most often in medRxiv. Dr. Farhadian's most frequent co-authors are Albert Icksang Ko, MD, Julio C. Silva, MD and Rupak Datta, MD, PhD.

Dr. Farhadian graduated from JS Weill Medical College, Cornell University in 2012.